跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Synflorix - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Synflorix
Approved
STANDARD
Synflorix
Glaxosmithkline Biologicals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f0239239b165ca3f
Company
Glaxosmithkline Biologicals
Type
Standard
Approval Details
Approval Id
f0239239b165ca3f
Drug Approval Philippines Name
Synflorix
Product Name
Synflorix
Registration Number
BR-1310
Brand Name
Synflorix
Generic Name
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Dosage Form
Suspension For Injection
Dosage Strength
0.5mL
Manufacturer
Glaxosmithkline Biologicals
Importer
Glaxosmithkline Philippines, Inc.
Distributor
Glaxosmithkline Philippines, Inc.
Company Detail Path
/organization/glaxosmithkline-biologicals
Issuance Date
06 December 2024
Expiry Date
22 January 2030
Pharmacologic Category
Vaccine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f0239239b165ca3f
Type
Standard
Back to Philippines FDA Approvals